Innovation

Pharmacologic Enhancement of Bacteriophage-Mediated Gene Transfer and Plasmid DNA-Mediated Gene Transfer in Mammalian Cells

University of Rochester
posted on 07/01/2009

Pharmacologic Enhancement of Bacteriophage-Mediated Gene Transfer and Plasmid DNA-Mediated Gene Transfer in Mammalian Cells

Suggested Uses

This technology proposes enhancing both bacteriophage-mediated gene transfer and plasmid DNA-mediated gene transfer in mammalian cells using pharmacological agents. This is applicable for vaccines as well as other gene transfer needs and as a research tool in the laboratory.

Advantages

These methods are advantageous as they enhance the gene activity achieved with bacteriopage-mediated or plasmid DNA-mediated delivery alone. More efficient gene transfer is possible by co-deliver agents that inhibit the proteosome or endosome acidification and by disrupting cellular microtubules. Additionally this may permit stronger immune responses and greater protein expression.


Innovation Details
 

Detailed Description

This technology proposes enhancing both bacteriophage-mediated gene transfer and plasmid DNA-mediated gene transfer in mammalian cells using pharmacological agents. This is applicable for vaccines as well as other gene transfer needs and as a research tool in the laboratory.

These methods are advantageous as they enhance the gene activity achieved with bacteriopage-mediated or plasmid DNA-mediated delivery alone. More efficient gene transfer is possible by co-deliver agents that inhibit the proteosome or endosome acidification and by disrupting cellular microtubules. Additionally this may permit stronger immune responses and greater protein expression.

File Number: 6-1629 

Other Information:

  • Refer to: Case # 6-1629
  • Lead Innovator: Dr. Stephen Dewhurst
  • Case Manager: Harl Tolbert
  • Harl_Tolbert@urmc.rochester.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Harl Tolbert at University of Rochester for more information.

request more info
People

Case Manager:

Icon_avatar Harl Tolbert

Innovations (25)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

4,069 members 12,307 innovations 109 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...